Back to BARCLAYS PLC BARCLAYS PLC

DNTHDNTH
Showing 8 of 11 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in DIANTHUS THERAPEUTICS INC

BARCLAYS PLC holds 431,753 shares of DNTH (DIANTHUS THERAPEUTICS INC), worth $42.1M as of 2026-Q2. The position was increased (+13.7% shares). DNTH represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$42.1M

Current Shares

431,753

Total Value Change

+$40.9M

Total Shares Change

+390,069

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
431,753
+13.7%
$42.1M0.0%$97.48
33
2026-Q1
Increased
379,606
+115.3%
$31.9M0.0%$55.39
47
2025-Q4
Decreased
176,300
-13.7%
$7.3M0.0%$40.96
0
2025-Q3
Increased
204,369
+215.3%
$8M0.0%$39.55
44
2025-Q2
Increased
64,821
+108.2%
$1.2M0.0%$17.63
41
2025-Q1
Decreased
31,141
-27.2%
$564,8970.0%$19.99
0
2024-Q4
Increased
42,766
+2.6%
$932,2980.0%$21.50
26
2024-Q3
Increased
41,684
+390.5%
$1.1M0.0%$27.24
41

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used